CECO Rises 16.1% YTD: Should You Buy the Stock Now or Wait?

CECO shares are up 16.1% year to date, supported by 35.2% Q2 2026 Engineered Systems revenue growth to $173.7 million, a 200% increase in segment orders to $672.1 million, and a record $1.8 billion backlog. Thermon acquisition synergies have reached roughly $13 million of annualized adjusted EBITDA savings versus a $40 million target, while 2026 EPS consensus rose 30% to $2.43. Offsetting these positives, CECO reported a $34.8 million GAAP Q2 net loss, gross margin fell 590bps to 30.3%, borrowings rose to $727.7 million, and its 22.51x forward P/E exceeds the 19.72x industry average; Zacks maintains a Hold view.

Analysis

CECO is transitioning from a project-equipment supplier into a more levered, integration-dependent industrial compounder. The key underwriting question is not order growth but conversion: fixed-price, long-duration projects create asymmetric downside if labor, steel, or execution costs rise before revenue recognition catches up. Thermon broadens the installed-base and aftermarket opportunity, but the acquisition must deliver both its targeted savings and stable organic demand to prevent leverage from constraining future bolt-ons or shareholder returns.

Near term, the stock is likely governed by the next two earnings prints: evidence that acquired margins normalize after purchase-accounting effects and that cash conversion reduces net leverage can support a rerating despite the premium multiple. Conversely, any cut to 2027 EPS expectations, a working-capital build, or leverage remaining above management's target after integration costs subside would expose CECO to multiple compression toward TTEK/DCI-style peer levels. A reversion from roughly 22.5x to 19.5x forward earnings alone implies about 13% downside before any estimate revision.

The less obvious read-through is favorable for specialized thermal-management and emissions-control suppliers serving gas-fired generation and power-intensive industrial capacity, but it is not automatically favorable for broad engineering consultants. CECO has more direct operating leverage to discrete project awards; TTEK's more diversified consulting model should be relatively insulated if power-project timing slips. Consensus may underweight the value of Thermon's recurring service and replacement demand, but that upside is a 6-18 month realization story rather than a reason to chase a near-term rebound.

The company claim around synergy capture needs independent validation through segment margin, free-cash-flow conversion, and customer retention—not adjusted EBITDA alone. Monitor order quality, cancellation language, project mix, and interest expense; these will determine whether incremental EBITDA accrues to equity holders or is absorbed by financing and integration costs.

Key Decisions for Investors

• Do not chase CECO over the next 1-3 months; place a buy watch at $60-62, where a further de-rating toward peer valuation offers a more attractive entry. Initiate only if the next report shows stable backlog conversion, positive free-cash-flow trajectory, and net leverage moving below 2.5x.
• For existing CECO exposure, retain a modest core position but hedge event risk with a 3-6 month collar around the next earnings release. Thesis fails if 2027 EPS consensus falls below $3.00 or net leverage remains above 2.7x after integration costs normalize.
• Express the execution-risk view as long TTEK / short CECO in equal dollar amounts over 1-3 months if CECO rallies without corresponding cash-flow evidence. The spread should benefit if project timing or acquisition integration disappoints; cover the short if CECO demonstrates sustained margin recovery and deleveraging.
• Set an alert for quarterly interest expense, working-capital use, and realized synergy run-rate. A credible path to $40M of savings plus debt paydown is the catalyst for a 6-18 month CECO long; absent those datapoints, treat the premium multiple as unsupported.